Assaying the Effect of Levodopa on the Evaluation of Risk in Healthy Humans

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Symmonds, Mkael ^a,b   Wright, Nicholas D ^a   Fagan, Elizabeth ^a   Dolan, Raymond J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACOGENETICS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SYNAPTIC TRANSMISSION;

ADOLESCENT; ADULT; ALGORITHMS; ANTIPARKINSON AGENTS; DECISION MAKING; FEMALE; GAMBLING; HUMANS; LEVODOPA; MALE; MODELS, PSYCHOLOGICAL; REWARD; RISK-TAKING; YOUNG ADULT;

EID: 84879749248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068177     Document Type: Article

References (85)

1. Rothschild M, Stiglitz JE, (1971) Increasing risk II: Its economic consequences. Journal of Economic Theory 3: 66-84.
2. Coombs CH, Pruitt DG, (1960) Components of risk in decision making: Probability and variance preferences. Journal of Experimental Psychology 60: 265-277.
3. D'Acremont M, Bossaerts P, (2008) Neurobiological studies of risk assessment: A comparison of expected utility and mean-variance approaches. Cognitive, Affective & Behavioral Neuroscience 8: 363-374.
4. Kacelnik A, Bateson M, (1996) Risky Theories-The Effects of Variance on Foraging Decisions. Amer Zool 36: 402-434.
5. Alderfer CP, (1970) Choices with risk: Beyond the mean and variance. The Journal of business 43: 341-353.
6. Golec J, Tamarkin M, (1998) Bettors Love Skewness, Not Risk, at the Horse Track. Journal of Political Economy 106: 205-225.
7. Fishburn PC, (1984) Foundations of Risk Measurement. I. Risk As Probable Loss. Management Science 30: 396-406.
8. Cools R, Barker RA, Sahakian BJ, Robbins TW, (2003) L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41: 1431-1441.
9. Torta DME, Castelli L, Zibetti M, Lopiano L, Geminiani G, (2009) On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: Does the therapy-dose matter? Brain and Cognition 71: 84-91.
10. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A, (2007) Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Movement Disorders 22: 1757-1763.
11. Molina JA, Sáinz Artiga MJ, Fraile A, Jiménez Jiménez FJ, Villanueva C, et al. (2000) Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment? Movement Disorders 15: 869-872.
12. Imamura A, Uitti RJ, Wszolek ZK, (2006) Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism & Related Disorders 12: 506-508.
13. Czernecki V, Pillon B, Houeto J, Pochon J, Levy R, et al. (2002) Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 40: 2257-2267.
14. St OngeJR, Floresco SB, (2008) Dopaminergic Modulation of Risk-Based Decision Making. Neuropsychopharmacology 34: 681-697.
15. Tobler PN, O'Doherty JP, Dolan RJ, Schultz W, (2007) Reward value coding distinct from risk attitude-related uncertainty coding in human reward systems. J Neurophysiol 97: 1621-1632.
16. Preuschoff K, Bossaerts P, Quartz SR, (2006) Neural differentiation of expected reward and risk in human subcortical structures. Neuron 51: 381-390.
17. Kuhnen CM, Knutson B, (2005) The neural basis of financial risk taking. Neuron 47: 763-770.
18. Abler B, Walter H, Erk S, Kammerer H, Spitzer M, (2006) Prediction error as a linear function of reward probability is coded in human nucleus accumbens. Neuroimage 31: 790-795.
19. Fiorillo CD, Tobler PN, Schultz W, (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299: 1898-1902.
20. Niv Y, Duff MO, Dayan P, (2005) Dopamine, uncertainty and TD learning. Behavioral and Brain Functions 1: 1-9.
21. Fiorillo CD, Tobler PN, Schultz W, (2005) Evidence that the delay-period activity of dopamine neurons corresponds to reward uncertainty rather than backpropagating TD errors. Behav Brain Funct 1: 7.
22. Schultz W, Dayan P, Montague PR, (1997) A neural substrate of prediction and reward. Science 275: 1593-1599.
23. Friston K, (2010) The free-energy principle: a unified brain theory? Nature Reviews Neuroscience 11: 127-138.
24. Tobler PN, Fiorillo CD, Schultz W, (2005) Adaptive coding of reward value by dopamine neurons. Science 307: 1642-1645.
25. Sevy S, Hassoun Y, Bechara A, Yechiam E, Napolitano B, et al. (2006) Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels. Psychopharmacology 188: 228-235.
26. Pothos EN, (2002) Regulation of dopamine quantal size in midbrain and hippocampal neurons. Behavioural brain research 130: 203-207.
27. Crevoisier C, Hoevels B, Zürcher G, Da Prada M, (1987) Bioavailability of L-dopa after Madopar HBS administration in healthy volunteers. European neurology 27: 36-46.
28. Symmonds M, Wright N, Bach D, Dolan R, (2011) Deconstructing risk: separable encoding of variance and skewness in the brain. Neuroimage 58: 1139-1149.
29. Pelli DG, Farell B (2009) Psychophysical methods. Handbook of Optics: Vision and vision optics.
30. Schwarz G, (1978) Estimating the dimension of a model. The Annals of Statistics 6: 461-464.
31. Penny W, Stephan K, Mechelli A, Friston K, (2004) Comparing dynamic causal models. Neuroimage 22: 1157-1172.
32. Levin IP, Weller JA, Pederson AA, Harshman LA, (2007) Age-related differences in adaptive decision making: Sensitivity to expected value in risky choice. Judgment and Decision Making 2: 225-233.
33. Brand M, Fujiwara E, Borsutzky S, Kalbe E, Kessler J, et al. (2005) Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions. Neuropsychology 19: 267-277.
34. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, et al. (1999) Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. The Journal of Neuroscience 19: 9029-9038.
35. Lejuez C, Read JP, Kahler CW, Richards JB, Ramsey SE, et al. (2002) Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART). Journal of Experimental Psychology: Applied 8: 75-84.
36. Symmonds M, Emmanuel J, Drew M, Batterham R, Dolan R, (2010) Metabolic state alters economic decision making under risk in humans. PLoS ONE 5: e11090.
37. Wright ND, Symmonds M, Hodgson K, Fitzgerald THB, Crawford B, et al. (2012) Approach-Avoidance Processes Contribute to Dissociable Impacts of Risk and Loss on Choice. The Journal of Neuroscience 32: 7009-7020.
38. Kaminski BJ, Ator NA, (2001) Behavioral and pharmacological variables affecting risky choice in rats. Journal of the Experimental Analysis of Behavior 75: 275-297.
39. Copland DA, (2009) Dopaminergic neuromodulation of semantic processing: A 4-T fMRI study with levodopa. Cerebral Cortex 19: 2651-2658.
40. Angwin AJ, Chenery HJ, Copland DA, Arnott WL, Murdoch BE, et al. (2004) Dopamine and semantic activation: an investigation of masked direct and indirect priming. Journal of the International Neuropsychological Society 10: 15-25.
41. Kischka U, Kammer TH, Maier S, Weisbrod M, Thimm M, et al. (1996) Dopaminergic modulation of semantic network activation. Neuropsychologia 34: 1107-1113.
42. Onur OA, Piefke M, Lie C-H, Thiel CM, Fink GR, (2011) Modulatory Effects of Levodopa on Cognitive Control in Young, but not in Older Subjects: A Pharmacological fMRI Study. Journal of cognitive neuroscience 23: 2797-2810.
43. Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, et al. (2004) Levodopa: faster and better word learning in normal humans. Annals of neurology 56: 20-26.
44. Floel A, Hummel F, Breitenstein C, Knecht S, Cohen L, (2005) Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology 65: 472-474.
45. de Vries MH, Ulte C, Zwitserlood P, Szymanski B, Knecht S, (2010) Increasing dopamine levels in the brain improves feedback-based procedural learning in healthy participants: an artificial-grammar-learning experiment. Neuropsychologia 48: 3193-3197.
46. Moran RJ, Symmonds M, Stephan KE, Friston KJ, Dolan RJ, (2011) An In Vivo Assay of Synaptic Function Mediating Human Cognition. Current Biology 21: 320-325.
47. Pleger B, Ruff CC, Blankenburg F, Kloppel S, Driver J, et al. (2009) Influence of dopaminergically mediated reward on somatosensory decision-making. PLoS Biol 7: e1000164.
48. Sharot T, Shiner T, Brown AC, Fan J, Dolan RJ, (2009) Dopamine enhances expectation of pleasure in humans. Current Biology 19: 2077-2080.
49. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD, (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442: 1042-1045.
50. Dethy S, Laute MA, Van Blercom N, Damhaut P, Goldman S, et al. (1997) Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients. Clinical chemistry 43: 740-744.
51. Buelow MT, Suhr JA, (2009) Construct validity of the Iowa gambling task. Neuropsychology review 19: 102-114.
52. Redish AD, (2004) Addiction as a computational process gone awry. Science 306: 1944-1947.
53. Daw ND, Kakade S, Dayan P, (2002) Opponent interactions between serotonin and dopamine. Neural Networks 15: 603-616.
54. Frank MJ, Seeberger LC, O'Reilly RC, (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306: 1940-1943.
55. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, et al. (2009) Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. The Journal of Neuroscience 29: 1538-1543.
56. Mihatsch O, Neuneier R, (2002) Risk-sensitive reinforcement learning. Machine learning 49: 267-290.
57. Niv Y, Edlund JA, Dayan P, O'Doherty JP, (2012) Neural prediction errors reveal a risk-sensitive reinforcement-learning process in the human brain. The Journal of Neuroscience 32: 551-562.
58. Kagel JH, Roth AE (1995) The handbook of experimental economics. Princeton, NJ.
59. Ellsberg D, (1961) Risk, ambiguity, and the Savage axioms. The Quarterly Journal of Economics 75: 643-669.
60. Bach DR, Dolan RJ, (2012) Knowing how much you don't know: a neural organization of uncertainty estimates. Nature Reviews Neuroscience 13: 572-586.
61. Delazer M, Sinz H, Zamarian L, Stockner H, Seppi K, et al. (2009) Decision making under risk and under ambiguity in Parkinson's disease. Neuropsychologia 47: 1901-1908.
62. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, et al. (2006) Problematic gambling on dopamine agonists: not such a rarity. Movement Disorders 21: 2206-2208.
63. Lu C, Bharmal A, Suchowersky O, (2006) Gambling and Parkinson disease. Archives of neurology 63: 298.
64. Tippmann-Peikert M, Park J, Boeve B, Shepard J, Silber M, (2007) Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68: 301-303.
65. Breitenstein C, Korsukewitz C, Flöel A, Kretzschmar T, Diederich K, et al. (2006) Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology 31: 2552-2564.
66. Niv Y, Daw ND, Joel D, Dayan P, (2007) Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology 191: 507-520.
67. Comings D, Gade R, Wu S, Chiu C, Dietz G, et al. (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Molecular Psychiatry 2: 44-56.
68. Takahashi H, Matsui H, Camerer C, Takano H, Kodaka F, et al. (2010) Dopamine D1 Receptors and Nonlinear Probability Weighting in Risky Choice. The Journal of Neuroscience 30: 16567-16572.
69. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, et al. (1996) A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics and Genomics 6: 223-234.
70. Lobo DSS, Souza RP, Tong RP, Casey DM, Hodgins DC, et al. (2010) Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biological psychology 85: 33-37.
71. Dreber A, Apicella CL, Eisenberg DTA, Garcia JR, Zamore RS, et al. (2009) The 7R polymorphism in the dopamine receptor D4 gene (DRD4) is associated with financial risk taking in men. Evolution and Human Behavior 30: 85-92.
72. Comings D, Gade Andavolu R, Gonzalez N, Wu S, Muhleman D, et al. (2001) The additive effect of neurotransmitter genes in pathological gambling. Clinical Genetics 60: 107-116.
73. Eisenegger C, Knoch D, Ebstein RP, Gianotti LRR, Sándor PS, et al. (2010) Dopamine receptor D4 polymorphism predicts the effect of L-DOPA on gambling behavior. Biological psychiatry 67: 702-706.
74. Camara E, Krämer UM, Cunillera T, Marco-Pallarés J, Cucurell D, et al. (2010) The Effects of COMT (Val108/158Met) and DRD4 (SNP- 521) Dopamine Genotypes on Brain Activations Related to Valence and Magnitude of Rewards. Cerebral Cortex 20: 1985-1996.
75. Forbes E, Brown S, Kimak M, Ferrell R, Manuck S, et al. (2007) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Molecular Psychiatry 14: 60-70.
76. Marco-Pallarés J, Cucurell D, Cunillera T, Krämer UM, Camara E, et al. (2009) Genetic variability in the dopamine system (dopamine receptor D4, catechol-O-methyltransferase) modulates neurophysiological responses to gains and losses. Biological psychiatry 66: 154-161.
77. Tanaka SC, Schweighofer N, Asahi S, Shishida K, Okamoto Y, et al. (2007) Serotonin differentially regulates short-and long-term prediction of rewards in the ventral and dorsal striatum. PLoS ONE 2: e1333.
78. McCabe C, Mishor Z, Cowen PJ, Harmer CJ, (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological psychiatry 67: 439-445.
79. Nakamura K, Matsumoto M, Hikosaka O, (2008) Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus. The Journal of Neuroscience 28: 5331-5343.
80. Tanaka SC, Shishida K, Schweighofer N, Okamoto Y, Yamawaki S, et al. (2009) Serotonin affects association of aversive outcomes to past actions. The Journal of Neuroscience 29: 15669-15674.
81. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, et al. (2003) Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28: 153-162.
82. Long AB, Kuhn CM, Platt ML, (2009) Serotonin shapes risky decision making in monkeys. Social Cognitive and Affective Neuroscience 4: 346-356.
83. Berridge KC, (1996) Food reward: brain substrates of wanting and liking. Neuroscience & Biobehavioral Reviews 20: 1-25.
84. Leibowitz SF, Alexander JT, (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biological psychiatry 44: 851-864.
85. Ha RY, Namkoong K, Kang JI, Kim YT, Kim SJ, (2009) Interaction between serotonin transporter promoter and dopamine receptor D4 polymorphisms on decision making. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33: 1217-1222.